Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
Dr Reddy’s Laboratories yesterday launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.
The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
- Advertisement -